[An efficient method for producing monoclonal antibodies against multi-pass membrane proteins]

Area of Science:

• Biotechnology
• Immunology
• Molecular Biology

Context:

• Monoclonal antibodies (mAbs) are crucial in medical science and pharmacology due to their specificity.
• Traditional mAb production methods struggle with multi-pass transmembrane proteins like GPCRs and transporters.
• Challenges include complex structures, limited extracellular regions, and high hydrophobicity.

Purpose:

• To develop a novel method for producing functional mAbs against multi-pass transmembrane proteins.
• To overcome difficulties in generating mAbs targeting extracellular regions of complex membrane proteins.
• To validate the efficacy of using GFP-fused proteins and optimized immunization for antibody generation.

Summary:

• A new strategy was employed to produce mAbs against a 12-pass transmembrane transporter using GFP-fused immunogens.
• Functional mAbs were successfully generated, recognizing the extracellular domain of the transporter on living cells.
• This approach was extended to produce mAbs against seven-transmembrane G-protein coupled receptors (GPCRs), specifically S1P receptors.

Impact:

• Enables the development of therapeutic and diagnostic tools targeting previously difficult-to-address membrane proteins.
• Advances the study of GPCRs and transporters by providing specific antibody probes.
• Paves the way for producing mAbs against a wider range of complex biological targets.